# VERA (Vera Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Vera Therapeutics, Inc. reported $465.8M in total assets and a net loss of $415.3M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/VERA
- Markdown: https://convexityos.com/fundamentals/VERA.md
- SEC CIK: 0001831828
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:22 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001831828&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$427.5M | Operating profit |
| Net Income | FY 2025 | -$415.3M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$5.76 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$376.0M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $384.0M | Total debt: $75.43M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $215.3M | $126.2M | $78.22M | $68.99M | $22.48M | $45.21M |
| Total Operating Expenses | $315.5M | $167.2M | $102.0M | $90.90M | $34.40M | $52.24M |
| **Operating Income** | -$315.5M | -$167.2M | -$102.0M | -$90.90M | -$34.40M | -$52.24M |
| **EBITDA** | -$315.0M | -$167.1M | -$102.0M | -$91.75M | -$34.23M | -$51.99M |
| Interest Income | $24.48M | $20.71M | $7.98M | $1.75M | $15K | $8.0K |
| Interest Expense | $7.53M | $7.63M | $3.79M | $992K | $20K | $166K |
| Income Before Tax | -$299.6M | -$152.1M | -$95.99M | -$89.06M | -$32.61M | -$53.41M |
| Income Tax Expense | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | -$1.0K |
| **Net Income** | -$299.6M | -$152.1M | -$95.99M | -$89.06M | -$32.61M | -$53.41M |
| Basic EPS | -$4.66 | -$2.75 | -$2.25 | -$3.35 | -$2.43 | -$166.93 |
| **Diluted EPS** | -$4.66 | -$2.75 | -$2.25 | -$3.35 | -$2.43 | -$166.93 |
| Basic Shares Outstanding | 64.2M | 55.3M | 42.7M | 26.6M | 13.4M | 320.0K |
| Diluted Shares Outstanding | 64.2M | 55.3M | 42.7M | 26.6M | 13.4M | 320.0K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $10.28M | -- | -- | -- | $0 | -- | -- | -- |
| Cost of Revenue | $3.30M | -- | -- | -- | $0 | -- | -- | -- |
| **Gross Profit** | $6.98M | -- | -- | -- | $0 | -- | -- | -- |
| Research & Development | $41.25M | $60.08M | $86.01M | $59.31M | $56.47M | $58.20M | $41.28M | $33.35M |
| Selling, General & Admin | $61.43M | -- | -- | -- | $27.46M | -- | -- | -- |
| Total Operating Expenses | -- | $112.5M | $125.1M | $94.21M | $83.93M | $80.14M | $57.19M | $48.91M |
| **Operating Income** | -$95.70M | -$112.5M | -$125.1M | -$94.21M | -$83.93M | -$80.14M | -$57.19M | -$48.91M |
| **EBITDA** | -$94.88M | -$112.4M | -$125.0M | -$94.07M | -$83.80M | -$80.02M | -$57.11M | -$48.86M |
| Interest Income | $4.34M | $5.35M | $6.36M | $5.52M | $5.74M | $6.32M | $6.91M | $6.66M |
| Interest Expense | $1.87M | $1.85M | $1.82M | $1.90M | $1.96M | $1.87M | $1.79M | $1.87M |
| **Net Income** | -$93.71M | -$109.5M | -$121.0M | -$91.10M | -$80.29M | -$76.53M | -$51.69M | -$43.42M |
| Basic EPS | -$1.30 | -$1.52 | -$1.69 | -- | -$1.26 | -$1.20 | -$0.81 | -- |
| **Diluted EPS** | -$1.30 | -$1.52 | -$1.69 | -- | -$1.26 | -$1.20 | -$0.81 | -- |
| Basic Shares Outstanding | 72.1M | 71.8M | 71.5M | -- | 63.8M | 63.8M | 63.7M | -- |
| Diluted Shares Outstanding | 72.1M | 71.8M | 71.5M | -- | 63.8M | 63.8M | 63.7M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $354.7M | $92.65M | $45.68M | $43.46M | $79.67M | $53.65M |
| Short-Term Investments | $359.9M | $548.2M | $115.0M | $71.19M | $0 | -- |
| **Cash & Short-Term Investments** | $714.6M | $640.9M | $160.7M | $114.7M | $79.67M | $53.65M |
| Accounts Receivable, Net | $0 | -- | -- | -- | -- | -- |
| Inventory | $0 | -- | -- | -- | -- | -- |
| Other Current Assets | $4.27M | $1.38M | $2.24M | $719K | $480K | $392K |
| **Total Current Assets** | $728.9M | $651.2M | $172.0M | $125.7M | $82.54M | $54.26M |
| Property, Plant & Equipment, Net | $1.37M | $960K | $92K | $51K | $0 | -- |
| Intangible Assets | $0 | -- | -- | -- | -- | -- |
| Long-Term Investments | -- | -- | $11K | $58K | $867K | $0 |
| Other Non-Current Assets | $5.85M | -- | -- | -- | -- | -- |
| **Total Non-Current Assets** | $5.85M | $4.46M | $3.52M | $5.74M | $1.21M | $293K |
| **Total Assets** | $734.7M | $655.7M | $175.5M | $131.4M | $83.75M | $54.55M |
| Accounts Payable | $21.90M | $7.67M | $11.12M | $11.99M | $1.39M | $909K |
| Other Current Liabilities | $3.0K | $217K | -- | -- | -- | -- |
| **Total Current Liabilities** | $53.45M | $25.37M | $22.30M | $25.60M | $7.69M | $2.41M |
| Long-Term Debt | $74.84M | $50.69M | $49.88M | $24.81M | $4.92M | $0 |
| Other Non-Current Liabilities | $1.92M | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $76.76M | $53.16M | $51.56M | $28.93M | $6.47M | $1.92M |
| **Total Liabilities** | $130.2M | $78.53M | $73.86M | $54.53M | $14.16M | $4.33M |
| **Total Debt (incl. Leases)** | $77.31M | $54.64M | $53.71M | $31.29M | $13.92M | $0 |
| Common Stock | $71K | $64K | $44K | $28K | -- | -- |
| Retained Earnings | -$760.9M | -$461.2M | -$309.1M | -$213.1M | -$124.1M | -$91.45M |
| Accumulated Other Comp. Income | $786K | $393K | $251K | -$224K | $0 | -- |
| **Total Stockholders' Equity** | $604.5M | $577.2M | $101.7M | $76.91M | $69.59M | -$89.35M |
| Total Equity | $604.5M | $577.2M | $101.7M | $76.91M | $69.59M | -$89.35M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $55.32M | $48.88M | $114.4M | $354.7M | $57.77M | $49.12M | $55.09M | $92.65M |
| Short-Term Investments | $328.7M | $450.3M | $482.4M | $359.9M | $439.6M | $507.7M | $534.7M | $548.2M |
| **Cash & Short-Term Investments** | $384.0M | $499.2M | $596.8M | $714.6M | $497.4M | $556.8M | $589.8M | $640.9M |
| Accounts Receivable, Net | $11.98M | -- | -- | $0 | -- | -- | -- | -- |
| Inventory | $7.08M | -- | -- | $0 | -- | -- | -- | -- |
| Other Current Assets | $6.91M | $4.21M | $2.50M | $4.27M | $1.15M | $1.62M | $1.79M | $1.38M |
| **Total Current Assets** | $441.3M | $527.5M | $615.8M | $728.9M | $511.3M | $571.4M | $606.1M | $651.2M |
| Property, Plant & Equipment, Net | -- | $813K | $945K | $1.37M | $1.16M | $1.15M | $1.06M | $960K |
| Intangible Assets | $20.50M | -- | -- | $0 | -- | -- | -- | -- |
| Other Non-Current Assets | $3.97M | $5.49M | $5.94M | $5.85M | -- | -- | -- | -- |
| **Total Non-Current Assets** | $24.47M | $5.49M | $5.94M | $5.85M | $6.19M | $7.17M | $4.09M | $4.46M |
| **Total Assets** | $465.8M | $533.0M | $621.7M | $734.7M | $517.5M | $578.5M | $610.2M | $655.7M |
| Accounts Payable | $20.17M | $14.57M | $13.91M | $21.90M | $17.95M | $13.16M | $9.26M | $7.67M |
| Other Current Liabilities | -- | -- | -- | $3.0K | -- | -- | -- | $217K |
| **Total Current Liabilities** | $55.77M | $48.32M | $45.15M | $53.45M | $41.88M | $33.55M | $21.89M | $25.37M |
| Long-Term Debt | $75.43M | $75.23M | $75.03M | $74.84M | $74.65M | $74.46M | $50.91M | $50.69M |
| Other Non-Current Liabilities | $1.36M | $1.68M | $1.86M | $1.92M | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $76.79M | $76.91M | $76.89M | $76.76M | $76.74M | $76.70M | $53.27M | $53.16M |
| **Total Liabilities** | $132.6M | $125.2M | $122.0M | $130.2M | $118.6M | $110.3M | $75.17M | $78.53M |
| **Total Debt (incl. Leases)** | $75.43M | $75.23M | $75.03M | $77.31M | $77.22M | $77.55M | $54.47M | $54.64M |
| Common Stock | $72K | $72K | $72K | $71K | $64K | $64K | $64K | $64K |
| Retained Earnings | -$1.09B | -$991.4M | -$881.9M | -$760.9M | -$669.8M | -$589.5M | -$512.9M | -$461.2M |
| Accumulated Other Comp. Income | -$704K | -$403K | -$156K | $786K | $881K | $527K | $654K | $393K |
| **Total Stockholders' Equity** | $333.2M | $407.8M | $499.7M | $604.5M | $398.9M | $468.3M | $535.0M | $577.2M |
| Total Equity | $333.2M | $407.8M | $499.7M | $604.5M | $398.9M | $468.3M | $535.0M | $577.2M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$299.6M | -$152.1M | -$95.99M | -$89.06M | -$32.61M | -$53.41M |
| Depreciation & Amortization | $468K | $105K | $21K | -$846K | $176K | $251K |
| Stock-Based Compensation | $37.93M | $20.80M | $11.49M | $8.89M | $3.01M | $331K |
| Change in Payables | $13.91M | -$3.45M | -$873K | $10.61M | $475K | $567K |
| **Operating Cash Flow** | -$241.1M | -$134.7M | -$92.18M | -$67.60M | -$23.71M | -$34.81M |
| Capital Expenditure | -$630K | -$972K | -$63K | -$62K | $0 | -$99K |
| **Free Cash Flow** | -$241.7M | -$135.7M | -$92.24M | -$67.66M | -$23.71M | -$34.91M |
| Purchases of Investments | -$310.4M | -$703.0M | -$224.9M | -$148.5M | $0 | -- |
| **Investing Cash Flow** | $194.3M | -$425.0M | -$39.43M | -$70.55M | -$4.20M | -$42K |
| Common Stock Issued | -- | -- | -- | $2.00M | $0 | -- |
| Share Repurchases | $0 | -$13K | $0 | -- | -- | -- |
| **Financing Cash Flow** | $308.9M | $606.7M | $133.5M | $101.9M | $53.88M | $85.29M |
| **Net Change in Cash** | $262.1M | $46.97M | $1.93M | -$36.22M | $25.97M | $50.44M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$93.71M | -$109.5M | -$121.0M | -$91.10M | -$80.29M | -$76.53M | -$51.69M | -$43.42M |
| Depreciation & Amortization | $823K | $132K | $140K | $135K | $129K | $119K | $85K | $55K |
| Stock-Based Compensation | $15.73M | $15.86M | $13.21M | $10.96M | $9.74M | $9.47M | $7.74M | $6.22M |
| Change in Payables | $5.60M | $664K | -$7.97M | $3.62M | $4.79M | $3.90M | $1.60M | $3.06M |
| **Operating Cash Flow** | -$99.18M | -$100.3M | -$106.5M | -$69.99M | -$61.91M | -$54.80M | -$54.41M | -$39.18M |
| Capital Expenditure | $0 | $0 | -$23K | -$102K | -$133K | -$208K | -$187K | -$645K |
| **Free Cash Flow** | -$99.18M | -$100.3M | -$106.5M | -$70.10M | -$62.04M | -$55.01M | -$54.59M | -$39.83M |
| Purchases of Investments | -$48.51M | -$98.06M | -$210.6M | -$24.50M | -$98.70M | -$97.26M | -$89.99M | -$294.0M |
| **Investing Cash Flow** | $101.9M | $32.86M | -$137.8M | $80.66M | $69.76M | $28.54M | $15.32M | -$221.4M |
| **Financing Cash Flow** | $3.71M | $1.92M | $3.94M | $286.3M | $797K | $20.29M | $1.53M | $326.0M |
| **Net Change in Cash** | $6.45M | -$65.47M | -$240.4M | $297.0M | $8.65M | -$5.97M | -$37.56M | $65.39M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -49.6% | -26.4% | -94.4% | -115.8% | -46.9% | -- |
| Return on Assets (ROA) | -40.8% | -23.2% | -54.7% | -67.8% | -38.9% | -97.9% |
| Current Ratio | 13.64x | 25.67x | 7.71x | 4.91x | 10.73x | 22.55x |
| Quick Ratio | 13.64x | 25.26x | 7.21x | 4.48x | 10.36x | 22.30x |
| Debt to Equity | 0.13x | 0.09x | 0.53x | 0.41x | 0.20x | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -124.6% | -98.6% | -73.8% | -49.6% | -63.2% | -46.6% | -32.8% | -26.4% |
| Return on Assets (ROA) | -89.2% | -75.4% | -59.3% | -40.8% | -48.7% | -37.7% | -28.8% | -23.2% |
| Current Ratio | 7.91x | 10.92x | 13.64x | 13.64x | 12.21x | 17.03x | 27.68x | 25.67x |
| Quick Ratio | 7.78x | 10.33x | 13.22x | 13.64x | 11.88x | 16.59x | 26.94x | 25.26x |
| Debt to Equity | 0.23x | 0.18x | 0.15x | 0.13x | 0.19x | 0.17x | 0.10x | 0.09x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
